Lifeward (NASDAQ:LFWD) Stock Price Expected to Rise, HC Wainwright Analyst Says

Lifeward (NASDAQ:LFWD) had its price target boosted by equities researchers at HC Wainwright to $10.00 in a research note issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 48.37% from the stock’s previous close.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $10.00.

Lifeward Price Performance

LFWD opened at $6.74 on Thursday. The stock’s 50 day simple moving average is $6.90 and its 200 day simple moving average is $7.40. The firm has a market cap of $10.31 million, a price-to-earnings ratio of -0.36 and a beta of 0.12. Lifeward has a 1 year low of $4.14 and a 1 year high of $23.04.

Lifeward (NASDAQ:LFWD) last announced its quarterly earnings data on Wednesday, March 18th. The company reported ($3.60) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($3.53). Lifeward had a negative net margin of 90.38% and a negative return on equity of 145.55%. The company had revenue of $5.08 million during the quarter, compared to the consensus estimate of $7.87 million. As a group, sell-side analysts anticipate that Lifeward will post -1.78 EPS for the current year.

Institutional Investors Weigh In On Lifeward

Several hedge funds have recently added to or reduced their stakes in the stock. HRT Financial LP increased its holdings in shares of Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock valued at $28,000 after acquiring an additional 29,423 shares in the last quarter. Virtu Financial LLC grew its position in Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after purchasing an additional 37,037 shares during the last quarter. Jane Street Group LLC increased its stake in Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock valued at $40,000 after purchasing an additional 29,927 shares in the last quarter. Finally, Citadel Advisors LLC increased its stake in Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares in the last quarter. 26.76% of the stock is owned by institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.